Share this post on:

Product Name :
Clindamycin phosphate

Search keywords :
Clindamycin phosphate

drugId :
null

Target Vo:
50S ribosomal subunit

Target Vo Short Name :
50S ribosomal subunit

Moa_Name:
50S ribosomal subunit inhibitors

First Approval Country :
United States

First Approval Date Filter:
1980

Origin Company_Name :

Active Company_Name :
Baxter Healthcare Corp

Active Indication_Name:
Lung Abscess

In Active Indication_Name:
Pneumococcal Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AMPK gamma 1 Antibody
V5-tag Antibody
NF-KB p105 Antibody (YA700): NF-KB p105 Antibody (YA700) is a non-conjugated and Mouse origined monoclonal antibody about 105 kDa, targeting to NF-KB p105 (5E3). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related